Grace Therapeutics to participate in H.C. Wainright global investment conference
Grace Therapeutics, Inc. (NASDAQ:GRCE) said it will participate in the H.C. Wainright 28th Annual Global Investment Conference.
PRINCETON, N.J., Sept.
03, 2026 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc.
NASDAQ:GRCE (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, novel, injectable formulation of nimodipine being developed for IV infusion to address significant unmet…